Christopher Ogden - 19 Mar 2024 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Christopher Ogden
Issuer symbol
CTMX
Transactions as of
19 Mar 2024
Net transactions value
-$6,196
Form type
4
Filing time
21 Mar 2024, 16:38:57 UTC
Previous filing
19 Jan 2024
Next filing
14 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale $6,196 -2,971 -3.4% $2.09 85,686 19 Mar 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
F2 Includes 60,310 restricted stock units.